OTC Markets OTCQB - Delayed Quote USD

ZIVO Bioscience, Inc. (ZIVO)

13.99
0.00
(0.00%)
At close: June 12 at 8:00:00 PM EDT
Loading Chart for ZIVO
  • Previous Close 13.99
  • Open 13.99
  • Bid 11.00 x 10000
  • Ask 14.98 x 10000
  • Day's Range 13.99 - 13.99
  • 52 Week Range 5.51 - 22.15
  • Volume 121
  • Avg. Volume 487
  • Market Cap (intraday) 53.351M
  • Beta (5Y Monthly) 0.04
  • PE Ratio (TTM) --
  • EPS (TTM) -4.88
  • Earnings Date Aug 12, 2025 - Aug 18, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.

www.zivobioscience.com

7

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ZIVO

View More

Performance Overview: ZIVO

Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ZIVO
34.93%
S&P 500 (^GSPC)
1.62%

1-Year Return

ZIVO
75.09%
S&P 500 (^GSPC)
10.00%

3-Year Return

ZIVO
29.77%
S&P 500 (^GSPC)
59.40%

5-Year Return

ZIVO
2,019.70%
S&P 500 (^GSPC)
96.53%

Compare To: ZIVO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZIVO

View More

Valuation Measures

Annual
As of 6/13/2025
  • Market Cap

    53.35M

  • Enterprise Value

    53.81M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    393.52

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    442.87

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -948.38%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    121.5k

  • Net Income Avi to Common (ttm)

    -16.32M

  • Diluted EPS (ttm)

    -4.88

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    517.19k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -404.17k

Research Analysis: ZIVO

View More

Company Insights: ZIVO

Research Reports: ZIVO

View More

People Also Watch